Retinal microvascular function and incidence and trajectories of clinically relevant depressive symptoms: the Maastricht Study

Publication date

2024-07

Authors

van Gennip, April C E
Gupta, Monideepa D
Houben, Alfons J H M
Berendschot, Tos T J M
Webers, Carroll A B
van Greevenbroek, Marleen M J
van der Kallen, Carla J H
Koster, Annemarie
Wesselius, Anke
Eussen, Simone J P M

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

cc_by

Abstract

BACKGROUND: Cerebral microvascular dysfunction may contribute to depression via disruption of brain structures involved in mood regulation, but evidence is limited. We investigated the association of retinal microvascular function, a proxy for microvascular function in the brain, with incidence and trajectories of clinically relevant depressive symptoms. METHODS: Longitudinal data are from The Maastricht Study of 5952 participants (59.9 ± 8.5 years/49.7% women) without clinically relevant depressive symptoms at baseline (2010-2017). Central retinal arteriolar equivalent and central retinal venular equivalent (CRAE and CRVE) and a composite score of flicker light-induced retinal arteriolar and venular dilation were assessed at baseline. We assessed incidence and trajectories of clinically relevant depressive symptoms (9-item Patient Health Questionnaire score ⩾10). Trajectories included continuously low prevalence (low, n = 5225 [87.8%]); early increasing, then chronic high prevalence (early-chronic, n = 157 [2.6%]); low, then increasing prevalence (late-increasing, n = 247 [4.2%]); and remitting prevalence (remitting, n = 323 [5.4%]). RESULTS: After a median follow-up of 7.0 years (range 1.0-11.0), 806 (13.5%) individuals had incident clinically relevant depressive symptoms. After full adjustment, a larger CRAE and CRVE were each associated with a lower risk of clinically relevant depressive symptoms (hazard ratios [HRs] per standard deviation [s.d.]: 0.89 [95% confidence interval (CI) 0.83-0.96] and 0.93 [0.86-0.99], respectively), while a lower flicker light-induced retinal dilation was associated with a higher risk of clinically relevant depressive symptoms (HR per s.d.: 1.10 [1.01-1.20]). Compared to the low trajectory, a larger CRAE was associated with lower odds of belonging to the early-chronic trajectory (OR: 0.83 [0.69-0.99]) and a lower flicker light-induced retinal dilation was associated with higher odds of belonging to the remitting trajectory (OR: 1.23 [1.07-1.43]). CONCLUSIONS: These findings support the hypothesis that cerebral microvascular dysfunction contributes to the development of depressive symptoms.

Keywords

depressive symptoms, epidemiology, longitudinal study, retinal microvascular function, trajectories, vascular depression, Journal Article

Citation

van Gennip, A C E, Gupta, M D, Houben, A J H M, Berendschot, T T J M, Webers, C A B, van Greevenbroek, M M J, van der Kallen, C J H, Koster, A, Wesselius, A, Eussen, S J P M, Schalkwijk, C G, de Galan, B E, Köhler, S, Schram, M T, Stehouwer, C D A & van Sloten, T T 2024, 'Retinal microvascular function and incidence and trajectories of clinically relevant depressive symptoms : the Maastricht Study', Psychological medicine, vol. 54, no. 10, pp. 2482-2491. https://doi.org/10.1017/S0033291724000618